Innospec (IOSP) Stock Price
Innospec Price
Over the last 19 years Innospec grew revenue by 6.4% annually, reaching 1.85 B USD. Earnings per share have grown at 6.6% per year over the last 18 years. For Innospec, the net margin of 1.9% is broadly stable versus 2.4% a few years ago. At today's price the dividend yield works out to roughly 1.90%. The payout ratio is around 109% of earnings. The dividend has grown at 13.5% per year over the past 19 years. The consensus 12-month price target for Innospec is 102.00 USD, about 25.0% above where the stock trades today. Of 9 analysts, 8 rate the stock a buy — an overall Buy consensus. The stock trades about 24% above its 52-week low.
Innospec stock price
Details
Stock Price
ⓘHow to Read This Chart
This chart tracks the historical stock price of Innospec over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.
Total Return vs. Price Return
The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.
Intraday Price Data
When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Innospec stock reacts to market openings, earnings releases, or breaking news throughout the trading session.
What to Look For
Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Innospec's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.
| Date | Innospec Price |
|---|---|
| 7/10/2026 | 81.62 USD |
| 7/9/2026 | 80.72 USD |
| 7/8/2026 | 81.39 USD |
| 7/7/2026 | 81.66 USD |
| 7/6/2026 | 81.95 USD |
| 7/2/2026 | 83.10 USD |
| 7/1/2026 | 81.77 USD |
| 6/30/2026 | 81.39 USD |
| 6/29/2026 | 80.58 USD |
| 6/26/2026 | 82.63 USD |
| 6/25/2026 | 82.81 USD |
| 6/24/2026 | 83.39 USD |
| 6/23/2026 | 81.84 USD |
| 6/22/2026 | 82.76 USD |
| 6/18/2026 | 82.85 USD |
| 6/17/2026 | 84.00 USD |
| 6/16/2026 | 84.16 USD |
| 6/15/2026 | 85.97 USD |
| 6/12/2026 | 86.82 USD |
| 6/11/2026 | 84.81 USD |
| 6/10/2026 | 83.62 USD |
| 6/9/2026 | 82.83 USD |
| 6/8/2026 | 81.38 USD |
| 6/5/2026 | 81.28 USD |
| 6/4/2026 | 80.61 USD |
| 6/3/2026 | 80.95 USD |
| 6/2/2026 | 82.57 USD |
| 6/1/2026 | 81.38 USD |
| 5/29/2026 | 82.68 USD |
| 5/28/2026 | 82.16 USD |
| 5/27/2026 | 82.06 USD |
| 5/26/2026 | 80.73 USD |
| 5/22/2026 | 79.18 USD |
| 5/21/2026 | 77.38 USD |
| 5/20/2026 | 77.90 USD |
| 5/19/2026 | 76.87 USD |
| 5/18/2026 | 79.05 USD |
| 5/15/2026 | 78.15 USD |
| 5/14/2026 | 80.00 USD |
| 5/13/2026 | 79.69 USD |
| 5/12/2026 | 80.44 USD |
| 5/11/2026 | 80.82 USD |
| 5/8/2026 | 80.55 USD |
| 5/7/2026 | 76.64 USD |
| 5/6/2026 | 77.67 USD |
| 5/5/2026 | 78.19 USD |
| 5/4/2026 | 76.48 USD |
| 5/1/2026 | 76.83 USD |
| 4/30/2026 | 76.26 USD |
| 4/29/2026 | 75.61 USD |
| 4/28/2026 | 76.64 USD |
| 4/27/2026 | 77.68 USD |
| 4/24/2026 | 77.15 USD |
| 4/23/2026 | 76.66 USD |
| 4/22/2026 | 74.97 USD |
| 4/21/2026 | 75.47 USD |
| 4/20/2026 | 75.48 USD |
| 4/17/2026 | 76.19 USD |
| 4/16/2026 | 75.09 USD |
| 4/15/2026 | 74.66 USD |
| 4/14/2026 | 75.22 USD |
| 4/13/2026 | 76.57 USD |
| 4/10/2026 | 75.66 USD |
| 4/9/2026 | 75.83 USD |
| 4/8/2026 | 75.76 USD |
| 4/7/2026 | 72.88 USD |
| 4/6/2026 | 72.24 USD |
| 4/2/2026 | 73.79 USD |
| 4/1/2026 | 73.60 USD |
| 3/31/2026 | 73.02 USD |
| 3/30/2026 | 73.19 USD |
| 3/27/2026 | 72.20 USD |
| 3/26/2026 | 72.37 USD |
| 3/25/2026 | 70.75 USD |
| 3/24/2026 | 67.90 USD |
| 3/23/2026 | 67.32 USD |
| 3/20/2026 | 65.89 USD |
| 3/19/2026 | 67.23 USD |
| 3/18/2026 | 67.23 USD |
| 3/17/2026 | 68.87 USD |
| 3/16/2026 | 68.12 USD |
| 3/13/2026 | 68.63 USD |
| 3/12/2026 | 68.83 USD |
| 3/11/2026 | 69.74 USD |
| 3/10/2026 | 70.60 USD |
| 3/9/2026 | 71.43 USD |
| 3/6/2026 | 72.11 USD |
| 3/5/2026 | 74.22 USD |
| 3/4/2026 | 77.02 USD |
| 3/3/2026 | 76.37 USD |
| 3/2/2026 | 77.04 USD |
| 2/27/2026 | 76.58 USD |
| 2/26/2026 | 77.58 USD |
| 2/25/2026 | 78.15 USD |
| 2/24/2026 | 79.30 USD |
| 2/23/2026 | 78.98 USD |
| 2/20/2026 | 81.22 USD |
| 2/19/2026 | 82.66 USD |
| 2/18/2026 | 86.36 USD |
| 2/17/2026 | 86.14 USD |
| 2/13/2026 | 86.58 USD |
| 2/12/2026 | 86.88 USD |
| 2/11/2026 | 88.42 USD |
| 2/10/2026 | 87.73 USD |
| 2/9/2026 | 86.14 USD |
| 2/6/2026 | 86.31 USD |
| 2/5/2026 | 85.99 USD |
| 2/4/2026 | 86.89 USD |
| 2/3/2026 | 83.96 USD |
| 2/2/2026 | 83.50 USD |
| 1/30/2026 | 81.72 USD |
| 1/29/2026 | 81.41 USD |
| 1/28/2026 | 79.26 USD |
| 1/27/2026 | 79.53 USD |
| 1/26/2026 | 80.26 USD |
| 1/23/2026 | 80.83 USD |
| 1/22/2026 | 81.65 USD |
| 1/21/2026 | 81.15 USD |
| 1/20/2026 | 79.25 USD |
| 1/16/2026 | 79.86 USD |
| 1/15/2026 | 81.89 USD |
| 1/14/2026 | 80.85 USD |
| 1/13/2026 | 80.18 USD |
| 1/12/2026 | 80.57 USD |
| 1/9/2026 | 80.04 USD |
| 1/8/2026 | 79.99 USD |
| 1/7/2026 | 78.48 USD |
| 1/6/2026 | 78.61 USD |
| 1/5/2026 | 78.23 USD |
| 1/2/2026 | 76.28 USD |
| 12/31/2025 | 76.54 USD |
| 12/30/2025 | 78.14 USD |
| 12/29/2025 | 78.56 USD |
| 12/26/2025 | 78.40 USD |
| 12/24/2025 | 78.12 USD |
| 12/23/2025 | 78.08 USD |
| 12/22/2025 | 77.88 USD |
| 12/19/2025 | 77.63 USD |
| 12/18/2025 | 79.31 USD |
| 12/17/2025 | 78.96 USD |
| 12/16/2025 | 77.99 USD |
| 12/15/2025 | 78.38 USD |
| 12/12/2025 | 78.19 USD |
| 12/11/2025 | 78.62 USD |
| 12/10/2025 | 78.48 USD |
| 12/9/2025 | 75.97 USD |
| 12/8/2025 | 74.95 USD |
| 12/5/2025 | 75.04 USD |
| 12/4/2025 | 74.01 USD |
| 12/3/2025 | 74.85 USD |
| 12/2/2025 | 74.37 USD |
| 12/1/2025 | 74.01 USD |
| 11/28/2025 | 74.76 USD |
| 11/26/2025 | 74.55 USD |
| 11/25/2025 | 74.53 USD |
| 11/24/2025 | 71.05 USD |
| 11/21/2025 | 72.13 USD |
| 11/20/2025 | 70.62 USD |
| 11/19/2025 | 70.87 USD |
| 11/18/2025 | 71.15 USD |
| 11/17/2025 | 72.23 USD |
| 11/14/2025 | 74.09 USD |
| 11/13/2025 | 74.77 USD |
| 11/12/2025 | 74.86 USD |
| 11/11/2025 | 75.66 USD |
| 11/10/2025 | 75.07 USD |
| 11/7/2025 | 76.46 USD |
| 11/6/2025 | 73.49 USD |
| 11/5/2025 | 74.01 USD |
| 11/4/2025 | 72.26 USD |
| 11/3/2025 | 73.65 USD |
| 10/31/2025 | 73.58 USD |
| 10/30/2025 | 73.10 USD |
| 10/29/2025 | 73.48 USD |
| 10/28/2025 | 75.26 USD |
| 10/27/2025 | 75.22 USD |
| 10/24/2025 | 76.32 USD |
| 10/23/2025 | 75.65 USD |
| 10/22/2025 | 75.89 USD |
| 10/21/2025 | 74.84 USD |
| 10/20/2025 | 74.39 USD |
| 10/17/2025 | 74.09 USD |
| 10/16/2025 | 74.19 USD |
| 10/15/2025 | 74.93 USD |
| 10/14/2025 | 74.43 USD |
| 10/13/2025 | 74.52 USD |
| 10/10/2025 | 73.93 USD |
| 10/9/2025 | 76.29 USD |
| 10/8/2025 | 78.50 USD |
| 10/7/2025 | 78.10 USD |
| 10/6/2025 | 78.81 USD |
| 10/3/2025 | 78.79 USD |
| 10/2/2025 | 78.61 USD |
| 10/1/2025 | 76.83 USD |
| 9/30/2025 | 77.16 USD |
| 9/29/2025 | 77.06 USD |
| 9/28/2025 | 77.06 USD |
| 9/25/2025 | 77.54 USD |
| 9/24/2025 | 77.59 USD |
| 9/23/2025 | 79.29 USD |
| 9/22/2025 | 79.21 USD |
| 9/19/2025 | 79.55 USD |
| 9/18/2025 | 82.09 USD |
| 9/17/2025 | 80.62 USD |
| 9/16/2025 | 81.23 USD |
| 9/15/2025 | 80.62 USD |
| 9/12/2025 | 82.70 USD |
| 9/11/2025 | 83.65 USD |
| 9/10/2025 | 83.08 USD |
| 9/9/2025 | 83.55 USD |
| 9/8/2025 | 85.20 USD |
| 9/5/2025 | 85.73 USD |
| 9/4/2025 | 85.86 USD |
| 9/3/2025 | 85.81 USD |
| 9/2/2025 | 87.09 USD |
| 8/29/2025 | 87.60 USD |
| 8/28/2025 | 87.59 USD |
| 8/27/2025 | 87.73 USD |
| 8/26/2025 | 85.93 USD |
| 8/25/2025 | 86.62 USD |
| 8/22/2025 | 87.13 USD |
| 8/21/2025 | 83.99 USD |
| 8/20/2025 | 83.65 USD |
| 8/19/2025 | 84.17 USD |
| 8/18/2025 | 83.30 USD |
| 8/15/2025 | 82.95 USD |
| 8/14/2025 | 83.47 USD |
| 8/13/2025 | 85.02 USD |
| 8/12/2025 | 82.61 USD |
| 8/11/2025 | 81.17 USD |
| 8/8/2025 | 81.45 USD |
| 8/7/2025 | 79.81 USD |
| 8/6/2025 | 78.01 USD |
| 8/5/2025 | 80.73 USD |
| 8/4/2025 | 79.35 USD |
| 7/31/2025 | 78.55 USD |
| 7/30/2025 | 79.90 USD |
| 7/29/2025 | 80.74 USD |
| 7/28/2025 | 82.05 USD |
| 7/27/2025 | 83.22 USD |
| 7/25/2025 | 84.40 USD |
| 7/24/2025 | 84.18 USD |
| 7/23/2025 | 85.82 USD |
| 7/22/2025 | 84.74 USD |
| 7/21/2025 | 83.55 USD |
| 7/18/2025 | 83.03 USD |
| 7/17/2025 | 85.01 USD |
| 7/16/2025 | 84.53 USD |
| 7/15/2025 | 85.08 USD |
Innospec Revenue, EBIT, Net Income
3 Years
5 Years
10 Years
25 Years
Max
Details
Innospec Income Statement, Balance Sheet, Cash Flow Statement
| REVENUEB USD |
|---|
| REVENUE GROWTH% |
| GROSS MARGIN% |
| GROSS INCOMEM USD |
| NET INCOMEM USD |
| NET INCOME GROWTH% |
| DIVIDENDDIV.USD |
| DIVIDEND GROWTHDIV. GROWTH% |
| SHARESM |
| 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025e | 2026e | 2027e |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.78 | 0.82 | 0.96 | 1.01 | 0.88 | 1.31 | 1.48 | 1.51 | 1.19 | 1.48 | 1.96 | 1.95 | 1.85 | 1.82 | 1.91 | 2.01 |
| 0.26 | 5.41 | 17.36 | 5.42 | -12.75 | 47.90 | 13.02 | 2.51 | -21.15 | 24.31 | 32.37 | -0.76 | -5.29 | -1.41 | 5.06 | 5.08 |
| 30.41 | 31.17 | 31.46 | 34.19 | 37.60 | 30.86 | 29.47 | 30.80 | 28.67 | 29.27 | 29.85 | 30.34 | 29.38 | 29.38 | 29.38 | 29.38 |
| 236.00 | 255.00 | 302.00 | 346.00 | 332.00 | 403.00 | 435.00 | 466.00 | 342.00 | 434.00 | 586.00 | 591.00 | 542.00 | 534.36 | 561.39 | 589.88 |
| 66.00 | 77.00 | 84.00 | 119.00 | 81.00 | 61.00 | 85.00 | 112.00 | 28.00 | 93.00 | 133.00 | 139.00 | 35.00 | 129.00 | 142.00 | 162.00 |
| 37.50 | 16.67 | 9.09 | 41.67 | -31.93 | -24.69 | 39.34 | 31.76 | -75.00 | 232.14 | 43.01 | 4.51 | -74.82 | 268.57 | 10.08 | 14.08 |
| – | 1.00 | 0.55 | 0.61 | 0.67 | 1.16 | 0.89 | 1.02 | 1.04 | 1.16 | 1.28 | 1.41 | 1.55 | 1.71 | 1.89 | 2.09 |
| – | – | -45.00 | 10.91 | 9.84 | 73.13 | -23.28 | 14.61 | 1.96 | 11.54 | 10.34 | 10.16 | 9.93 | 10.32 | 10.53 | 10.58 |
| 23.90 | 24.20 | 24.90 | 24.60 | 24.40 | 24.50 | 24.60 | 24.70 | 24.80 | 24.90 | 25.00 | 25.02 | 25.12 | 25.12 | 25.12 | 25.12 |
Details
Income Statement Key Figures
ⓘRevenue and Revenue Growth
Revenue is the starting point of every income statement — it measures the total sales Innospec generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.
Gross Margin
Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Innospec retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Innospec's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.
EBIT and EBIT Margin
EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.
Net Income and Earnings Per Share (EPS)
Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.
Shares Outstanding
The total number of shares Innospec has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.
Analyst Estimates
The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Innospec's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.
Innospec stock margins
3 Years
5 Years
10 Years
25 Years
Max
Details
Innospec Stock Revenue, EBIT, Earnings per Share
3 Years
5 Years
10 Years
25 Years
Max
Details
Innospec business model & stock analysis
Innospec SWOT Analysis
Strengths
Innospec Inc possesses several notable strengths that contribute to its success in the market. - Strong Research and Development capabilities allow for continuous innovation and product improvement. - Well-established global presence with a diverse customer base provides stability and market reach. - Extensive industry experience and technical expertise enable the company to deliver high-quality products and services. - Strong financial position with positive cash flows and consistent revenue growth ensures long-term sustainability.
Weaknesses
Despite its strengths, Innospec Inc also faces certain weaknesses that need to be addressed. - Dependence on limited product lines or markets may pose risks associated with market fluctuations. - Reliance on key suppliers or partners increases vulnerability to supply chain disruptions. - Limited brand recognition compared to major competitors may hinder market penetration. - Slow response to market changes or technology advancements might result in missed opportunities.
Opportunities
Innospec Inc can leverage various opportunities in the market to further grow and expand its business. - Increasing demand for environmentally friendly products opens doors for sustainable product lines. - Expansion into emerging markets presents opportunities for geographical diversification. - Collaborations or partnerships with complementary businesses can enhance innovation and market presence. - Technological advancements offer possibilities to develop new solutions and gain a competitive edge.
Threats
Innospec Inc faces certain threats that may impact its growth and profitability in the future. - Intense competition within the industry poses challenges in terms of pricing and market share. - Regulatory changes or compliance requirements may increase costs and restrict business operations. - Economic downturns or global financial instability can affect customer spending and demand. - Volatility in raw material prices or availability may disrupt the supply chain and increase costs.
Innospec Segments
Innospec Revenue by Segment
3 Years
5 Years
10 Years
Max
Details
Innospec Revenue by Region
3 Years
5 Years
10 Years
Max
Details
Innospec Eulerpool Fair Value
Details
Fair Value Estimate
ⓘWhat Is Fair Value?
Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.
Earnings-Based Fair Value
Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.
Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021
Revenue-Based Fair Value
Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"
Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021
Dividend-Based Fair Value
Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.
Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021
How to Use This Chart
When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.
Innospec historical P/E ratio, EBIT multiple, and P/S ratio
Innospec annual returns
Details
Annual Return
ⓘWhat This Chart Shows
This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.
Price Return
Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.
Dividend Return
Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.
What to Look For
Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.
Innospec shares outstanding
3 Years
5 Years
10 Years
25 Years
Max
Details
Innospec stock splits
Innospec Dividend History
23 years of dividend payments · 7 consecutive increases
Innospec dividend history and estimates
3 Years
5 Years
10 Years
25 Years
Max
Details
Innospec dividend payout ratio
3 Years
5 Years
10 Years
25 Years
Max
Details
Current Innospec forecasts and price targets in July 2026
Analyst Price Targets 2026| Δ MOM Price Target | 0.00 % |
| Buy | 88.89 % (8) |
| Hold | 11.11 % (1) |
| Sell | 0.00 % (0) |
| 12M Price Target | 102.00 |
| Last Price | 81.64 |
| Currency | USD |
| 12M Return Potential | 24.94 % |
| LTM Return | 0 % |
Innospec Earnings Estimates
| Date | EPS estimate | Revenue Estimate | Quarterly report |
|---|---|---|---|
| 5/7/2026 | 1.06USD | 443.70 MUSD | 2026 Q1 |
| 2/17/2026 | 1.26USD | 470.08 MUSD | 2025 Q4 |
| 5/1/2024 | 1.64USD | 494.75 MUSD | 2024 Q1 |
| 2/19/2024 | 1.65USD | 494.19 MUSD | 2023 Q4 |
| 11/6/2023 | 1.79USD | 516.53 MUSD | 2023 Q3 |
| 7/31/2023 | 1.67USD | 498.92 MUSD | 2023 Q2 |
| 5/1/2023 | 1.76USD | 512.98 MUSD | 2023 Q1 |
| 2/13/2023 | 1.48USD | 480.81 MUSD | 2022 Q4 |
| 11/8/2022 | 1.44USD | 470.96 MUSD | 2022 Q3 |
| 8/2/2022 | 1.39USD | 447.95 MUSD | 2022 Q2 |
EESG©
Eulerpool ESG Scorecard© for the Innospec stock
EEnvironment
20
Environment
SSocial
20
Social
GGovernance (Corporate Governance)
4
Governance (Corporate Governance)
The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.
Innospec shareholder structure
| % | Name |
|---|---|
13.41376% | |
12.56993% | |
9.52167% | |
4.65355% | |
3.86251% | |
3.81578% |
Innospec Executives and Management Board
Mr. Patrick Williams
(60)President, Chief Executive Officer, Director · since 2005
Mr. Ian Cleminson
(59)Chief Financial Officer, Executive Vice President
Mr. David Jones
(56)Senior Vice President, Chief Compliance Officer, General Counsel, Company Secretary
Mr. Corbin Barnes
(52)Senior Vice President, Corporate Development and Investor Relations
Dr. Ian Mcrobbie
(76)Senior Vice President, Chief Technology Officer
Innospec Supply Chain
Innospec Supply Chain
Correlation: how closely stock prices move together
| # | Name | 1M | 3M | 6M | 1Y | 2Y | Trend |
|---|---|---|---|---|---|---|---|
| 1 | -0.27 | -0.03 | 0.39 | 0.49 | 0.57 | ||
| 2 | AARTI Industries | -0.86 | -0.02 | 0.04 | -0.11 | 0.49 |
Frequently asked questions about Innospec
The business model of Innospec Inc revolves around providing innovative specialty chemicals and technologies to a wide range of industries. Innospec specializes in developing and supplying fuel additives, performance chemicals, and oilfield chemicals, among others. With a focus on creating value-added solutions, the company aims to enhance the performance, efficiency, and sustainability of its customers' products and processes. Innospec's diverse product portfolio and extensive research capabilities enable it to cater to the evolving needs of various industries, including fuel, personal care, home care, pharmaceuticals, and more. By combining innovation, technical expertise, and customer-centric approach, Innospec strives to be a trusted partner for its clients' chemical requirements.
Innospec stock
Innospec Peer Group
Innospec Ticker
Innospec FIGI
All fundamentals and in-depth analysis of Innospec
Our stock analysis for Innospec stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Innospec. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.